首页> 外文期刊>Journal of cardiopulmonary rehabilitation and prevention >Differences in hemodynamic parameters and exercise capacity between patients with pulmonary arterial hypertension and chronic heart failure
【24h】

Differences in hemodynamic parameters and exercise capacity between patients with pulmonary arterial hypertension and chronic heart failure

机译:肺动脉高压和慢性心力衰竭患者血液动力学参数和运动能力的差异

获取原文
获取原文并翻译 | 示例
       

摘要

INTRODUCTION: Although pulmonary arterial hypertension (PAH) and chronic heart failure (CHF) lead to exercise limitation, their pathophysiology is different. Our objective was to evaluate, using right heart catheterization and cardiopulmonary exercise testing, the difference in hemodynamic parameters and exercise capacity between PAH and CHF, which have the same subjective symptoms. METHODS: We studied 20 PAH (mean pulmonary artery pressure: 36 ± 10 mmHg, all . 25 mmHg) and 20 CHF (ejection fraction: 35 ± 10%, all < 40%) patients who underwent both cardiopulmonary exercise testing and right heart catheterization. All patients were in New York Heart Association functional class II or III. RESULTS: Peak oxygen uptake (VO2) was lower for PAH patients than for CHF patients (11.7 ± 3.2 mL?kg?min vs 14.5 ± 4.6 mL?kg?min, P = .03), while the slope of ventilation to carbon dioxide production ratio (VE/VCO2) was higher for PAH patients than for CHF patients (41.0 ± 12.7 vs 28.0 ± 9.0, P = .001), despite the similarity in their New York Heart Association functional class. Peak VO2 and VE/VCO2 correlated with cardiac index for both groups. An important finding was that peak VO2 correlated with pulmonary vascular resistance for PAH patients (r = 20.46, P = .04) but not for CHF patients (r = 0.33, P = .15). Furthermore, peak VO2 correlated with pulmonary capillary wedge pressure for CHF patients (r = 20.47, P = .03) but not for PAH patients (r = 0.17, P = .47), while the VE/VCO2 slope correlated with pulmonary capillary wedge pressure (r = 0.67, P = .002) but not with pulmonary vascular resistance (r = 0.12, P = .63) for CHF patients. CONCLUSION: Peak VO2 and VE/VCO2 slope were worse for PAH patients than for CHF patients despite the similar subjective symptoms. This difference might be explained by an altered hemodynamic status.
机译:简介:尽管肺动脉高压(PAH)和慢性心力衰竭(CHF)导致运动受限,但其病理生理却有所不同。我们的目标是使用右心导管检查和心肺运动测试来评估具有相同主观症状的PAH和CHF之间的血液动力学参数和运动能力的差异。方法:我们研究了20位接受了心肺运动测试和右心导管检查的PAH(平均肺动脉压:36±10 mmHg,所有25 mmHg)和20 CHF(射血分数:35±10%,所有<40%)患者。所有患者均属于纽约心脏协会功能性II级或III级。结果:PAH患者的峰值摄氧量(VO2)低于CHF患者(11.7±3.2 mL?kg?min vs 14.5±4.6 mL?kg?min,P = .03),而通气对二氧化碳的斜率尽管纽约心脏协会功能类别相似,但PAH患者的血生成比(VE / VCO2)却比CHF患者高(41.0±12.7 vs 28.0±9.0,P = .001)。两组的VO2和VE / VCO2峰值均与心脏指数相关。一个重要发现是,PAH患者的VO2峰值与肺血管阻力相关(r = 20.46,P = .04),而对于CHF患者则不相关(r = 0.33,P = .15)。此外,CHF患者的VO2峰值与肺毛细血管楔压相关(r = 20.47,P = .03),而对于PAH患者,VO2的峰值VO2与肺毛细血管楔压相关(r = 0.17,P = .47),而VE / VCO2斜率与肺毛细血管楔压相关CHF患者的血压(r = 0.67,P = .002),但不具有肺血管阻力(r = 0.12,P = .63)。结论:尽管有类似的主观症状,但PAH患者的峰值VO2和VE / VCO2斜率比CHF患者差。这种差异可以通过改变血流动力学状态来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号